Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BCTX | US
-0.04
-5.17%
Healthcare
Biotechnology
30/04/2024
21/10/2024
0.80
0.82
0.85
0.76
BriaCell Therapeutics Corp. an immuno-oncology-focused biotechnology company engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx a diagnostic test that determines the patients' HLA types. It has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates; and a cooperative research and development agreement with the National Cancer Institute to conduct preclinical studies to develop and test Bria-OTS cellular immunotherapy as a treatment for cancer. BriaCell Therapeutics Corp. is based in West Vancouver Canada.
View LessPrice Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
112.5%1 month
256.8%3 months
167.7%6 months
141.6%-
-
17.03
-
-
-1.38
-
-
-35.25M
28.57M
28.57M
-
-
-
-
-206.01
0.04
1.56
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.44
Range1M
0.80
Range3M
1.50
Rel. volume
0.20
Price X volume
685.21K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Fortress Biotech Inc | FBIOP | Biotechnology | 5.84 | 31.35M | 1.39% | n/a | 494.61% |
DarT Bioscience Inc | DARE | Biotechnology | 3.635 | 31.07M | -2.55% | 0.12 | 218.34% |
Surrozen Inc. Common Stock | SRZN | Biotechnology | 9.38 | 30.07M | -5.06% | n/a | 35.73% |
Longeveron Inc. Class A Common Stock | LGVN | Biotechnology | 2.09 | 30.01M | -4.57% | n/a | 11.72% |
Mawson Infrastructure Group Inc. Common Stock | MIGI | Biotechnology | 1.58 | 29.31M | -0.63% | n/a | 571.64% |
Nuo Therapeutics Inc | AURX | Biotechnology | 0.6216 | 28.97M | 0.00% | n/a | 0.00% |
Kala Pharmaceuticals Inc | KALA | Biotechnology | 5.24 | 28.72M | 0.77% | n/a | 268.29% |
NRXBF | NRXBF | Biotechnology | 0.4014 | 28.59M | 3.72% | n/a | 0.00% |
ProMIS Neurosciences Inc. | PMN | Biotechnology | 0.95 | 28.39M | -4.05% | n/a | 0.00% |
iBio Inc | IBIO | Biotechnology | 3.09 | 28.24M | 7.67% | n/a | 20.92% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 13.44 | 20.47M | 4.19% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 1 | 18.06M | -2.91% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5263 | 7.69M | -2.17% | 0.03 | 16.03% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4659 | 4.44M | -2.96% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.65 | 2.01M | -6.89% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -1.38 | 0.53 | Cheaper |
Ent. to Revenue | - | 3,967.00 | - |
PE Ratio | - | 41.03 | - |
Price to Book | 17.03 | 15.55 | Par |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 167.74 | 72.80 | Riskier |
Debt to Equity | - | -1.23 | - |
Debt to Assets | - | 0.25 | - |
Market Cap | 28.57M | 3.66B | Emerging |